SCN2A and Febrile seizure (within the age range of 3 months to 6 years): Variants in SCN1A and SCN2A have been linked to a spectrum of epilepsy phenotypes, including DS, generalised epilepsy with febrile seizures plus (GEFS+), WS and some other infantile epileptic disorders (34).